379 related articles for article (PubMed ID: 29260229)
1. Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.
Gamble C; Krishan A; Stocken D; Lewis S; Juszczak E; Doré C; Williamson PR; Altman DG; Montgomery A; Lim P; Berlin J; Senn S; Day S; Barbachano Y; Loder E
JAMA; 2017 Dec; 318(23):2337-2343. PubMed ID: 29260229
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
[TBL] [Abstract][Full Text] [Related]
4. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
5. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
Tunn R; Boutron I; Chan AW; Collins GS; Hróbjartsson A; Moher D; Schulz KF; de Beyer JA; Hansen Nejstgaard C; Østengaard L; Hopewell S
J Clin Epidemiol; 2024 May; 169():111309. PubMed ID: 38428538
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.
Kendall TJ; Robinson M; Brierley DJ; Lim SJ; O'Connor DJ; Shaaban AM; Lewis I; Chan AW; Harrison DJ;
Lancet Oncol; 2021 Oct; 22(10):e435-e445. PubMed ID: 34592193
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
[TBL] [Abstract][Full Text] [Related]
8. Involving patients and the public In sTatistIcal Analysis pLans (INITIAL): A delphi survey.
Goulão B; Morris TP; Blazeby J; Gamble C; Gillies K; Laidlaw L; Ramsay C; Soulsby I; Stewart D; Totton N
PLoS One; 2023; 18(12):e0292257. PubMed ID: 38096223
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
Orkin AM; Gill PJ; Ghersi D; Campbell L; Sugarman J; Emsley R; Steg PG; Weijer C; Simes J; Rombey T; Williams HC; Wittes J; Moher D; Richards DP; Kasamon Y; Getz K; Hopewell S; Dickersin K; Wu T; Ayala AP; Schulz KF; Calleja S; Boutron I; Ross JS; Golub RM; Khan KM; Mulrow C; Siegfried N; Heber J; Lee N; Kearney PR; Wanyenze RK; Hróbjartsson A; Williams R; Bhandari N; Jüni P; Chan AW;
JAMA; 2021 Jul; 326(3):257-265. PubMed ID: 34152382
[TBL] [Abstract][Full Text] [Related]
12. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
[TBL] [Abstract][Full Text] [Related]
13. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
[TBL] [Abstract][Full Text] [Related]
14. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
Trials; 2015 Sep; 16():417. PubMed ID: 26385379
[TBL] [Abstract][Full Text] [Related]
15. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.
Lee H; Cashin AG; Lamb SE; Hopewell S; Vansteelandt S; VanderWeele TJ; MacKinnon DP; Mansell G; Collins GS; Golub RM; McAuley JH; ; Localio AR; van Amelsvoort L; Guallar E; Rijnhart J; Goldsmith K; Fairchild AJ; Lewis CC; Kamper SJ; Williams CM; Henschke N
JAMA; 2021 Sep; 326(11):1045-1056. PubMed ID: 34546296
[TBL] [Abstract][Full Text] [Related]
16. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.
Butcher NJ; Mew EJ; Monsour A; Chan AW; Moher D; Offringa M
Trials; 2020 Jul; 21(1):620. PubMed ID: 32641085
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ; ; ;
Nat Med; 2020 Sep; 26(9):1351-1363. PubMed ID: 32908284
[TBL] [Abstract][Full Text] [Related]
18. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.
Liu X; Cruz Rivera S; Moher D; Calvert MJ; Denniston AK;
Lancet Digit Health; 2020 Oct; 2(10):e537-e548. PubMed ID: 33328048
[TBL] [Abstract][Full Text] [Related]
19. Developing a guideline for clinical trial protocol content: Delphi consensus survey.
Tetzlaff JM; Moher D; Chan AW
Trials; 2012 Sep; 13():176. PubMed ID: 23006145
[TBL] [Abstract][Full Text] [Related]
20. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
Solovyeva O; Dimairo M; Weir CJ; Hee SW; Espinasse A; Ursino M; Patel D; Kightley A; Hughes S; Jaki T; Mander A; Evans TRJ; Lee S; Hopewell S; Rantell KR; Chan AW; Bedding A; Stephens R; Richards D; Roberts L; Kirkpatrick J; de Bono J; Yap C
BMC Med; 2023 Jul; 21(1):246. PubMed ID: 37408015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
